Baijin Life Science Holdings Ltd HKEX:1466:
EXPECTS LOSS OF UP TO HK$43 MILLION FOR YEAR ENDED 31 MARCH 2026
EXPECTED FY LOSS MAINLY DUE TO LOWER JEWELLERY REVENUE AND HIGHER SKINCARE SELLING EXPENSES
Reuters
Baijin Life Science Expects FY Loss Of Up To HK$43 Million
- Sources
- Reuters
- Markets
- Stocks
- Active symbols
- HKEX:1466
- Language
- English
Baijin Life Science Holdings Ltd HKEX:1466: